| scholarly article | Q13442814 |
| P50 | author | Randy J. Nelson | Q37371556 |
| Silvana Chiavegatto | Q42755893 | ||
| Ronald L Schnaar | Q42852048 | ||
| P2093 | author name string | Sun J | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | knockout mouse | Q1364740 |
| P304 | page(s) | 227-234 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice | |
| P478 | volume | 166 |
| Q24602345 | Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes |
| Q84739890 | Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice |
| Q44175484 | Anti-ganglioside antibodies bind with enhanced affinity to gangliosides containing very long chain fatty acids |
| Q34157779 | Beta1,4-N-acetylgalactosaminyltransferase--GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides |
| Q35153204 | Biosynthesis and degradation of mammalian glycosphingolipids |
| Q34346493 | Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration |
| Q100454969 | Caveolin 1 is required for axonal outgrowth of motor neurons and affects Xenopus neuromuscular development |
| Q44102376 | Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. |
| Q48698146 | Conditional LoxP-flanked glucosylceramide synthase allele controlling glycosphingolipid synthesis |
| Q48466996 | Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans |
| Q50667993 | Deficits in cognitive function and hippocampal plasticity in GM2/GD2 synthase knockout mice. |
| Q47154575 | Disease-modifying effects of ganglioside GM1 in Huntington's disease models. |
| Q56356639 | Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation |
| Q38587703 | Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach. |
| Q47070636 | Drosophila egghead encodes a beta 1,4-mannosyltransferase predicted to form the immediate precursor glycosphingolipid substrate for brainiac |
| Q39229360 | Effect of ganglioside GM3 synthase gene knockout on the glycoprotein N-glycan profile of mouse embryonic fibroblast |
| Q46818702 | Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1. |
| Q51040506 | First total synthesis of ganglioside DSG-A possessing neuritogenic activity. |
| Q35186924 | Functional role of a specific ganglioside in neuronal migration and neurite outgrowth |
| Q37494316 | Functional roles of gangliosides in neurodevelopment: an overview of recent advances |
| Q30383741 | Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells |
| Q49829715 | Ganglioside Metabolism and Parkinson's Disease |
| Q35361488 | Ganglioside biochemistry |
| Q34955771 | Ganglioside function in calcium homeostasis and signaling |
| Q38352766 | Ganglioside/calmodulin kinase II signal inducing cdc42-mediated neuronal actin reorganization |
| Q56772126 | Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers |
| Q38853822 | Gangliosides of the Vertebrate Nervous System |
| Q37027396 | Glycan antagonists and inhibitors: a fount for drug discovery |
| Q35153220 | Glycosphingolipid functions: insights from engineered mouse models |
| Q38155963 | Glycosphingolipids: synthesis and functions |
| Q38241672 | Human genetic disorders of sphingolipid biosynthesis |
| Q39726453 | Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1. |
| Q33334765 | Impaired hypoglossal nerve regeneration in mutant mice lacking complex gangliosides: down-regulation of neurotrophic factors and receptors as possible mechanisms |
| Q38859739 | Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis |
| Q33863886 | Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions |
| Q35931476 | It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation |
| Q90379387 | Lipids in the Physiopathology of Hereditary Spastic Paraplegias |
| Q35161290 | Mice lacking major brain gangliosides develop parkinsonism |
| Q35751923 | Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. |
| Q33943783 | Myelin-associated glycoprotein and its axonal receptors |
| Q64120650 | Neuronal Signaling by Thy-1 in Nanodomains With Specific Ganglioside Composition: Shall We Open the Door to a New Complexity? |
| Q37479514 | Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice. |
| Q48492427 | Neuroplastin expression in the hippocampus of mice lacking complex gangliosides |
| Q58555785 | Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder |
| Q38218040 | Pathogenic role of ganglioside metabolism in neurodegenerative diseases |
| Q37535345 | Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction |
| Q37648392 | Physiological Exploration of the Long Term Evolutionary Selection against Expression of N-Glycolylneuraminic Acid in the Brain |
| Q26995291 | Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration |
| Q35774811 | Sialylation regulates brain structure and function |
| Q34577669 | Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function |
| Q93169003 | Sphingolipid dyshomeostasis in the brain of the mouse model of mucopolysaccharidosis type IIIA |
| Q39342245 | Sphingolipids: membrane microdomains in brain development, function and neurological diseases. |
| Q33453583 | Structural characterization of monosialo-, disialo- and trisialo-gangliosides by negative ion AP-MALDI-QIT-TOF mass spectrometry with MS(n) switching |
| Q37936732 | Structures, biosynthesis, and functions of gangliosides--an overview |
| Q45130172 | Susceptibility of cerebellar granule neurons from GM2/GD2 synthase-null mice to apoptosis induced by glutamate excitotoxicity and elevated KCl: rescue by GM1 and LIGA20. |
| Q38900943 | TALEN mediated targeted editing of GM2/GD2-synthase gene modulates anchorage independent growth by reducing anoikis resistance in mouse tumor cells |
| Q47144233 | The Enigmatic Role of GBA2 in Controlling Locomotor Function |
| Q37152815 | The chemical neurobiology of carbohydrates |
| Q41249640 | The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice |
| Q35949413 | The mdx Mutation in the 129/Sv Background Results in a Milder Phenotype: Transcriptome Comparative Analysis Searching for the Protective Factors |
| Q51722538 | The regulation of ER export and Golgi retention of ST3Gal5 (GM3/GM4 synthase) and B4GalNAcT1 (GM2/GD2/GA2 synthase) by arginine/lysine-based motif adjacent to the transmembrane domain. |
| Q38501568 | The role of gangliosides in neurodevelopment. |
| Q48639806 | Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice |
Search more.